The study pointed to as much as a 33% increase in the relative risk of suffering a heart attack while taking Pradaxa®
St. Louis, Missouri (PRWEB) July 17, 2012
The nationwide pharmaceutical litigation law firm of Kell Lampin, LLC is actively investigating potential Pradaxa® heart attack lawsuits and Pradaxa® bleeding lawsuits. The attorneys of Kell Lampin, LLC have over 25 years of experience in handling and trying serious personal injury claims. The firm’s attorneys are currently providing free, no obligation, and confidential case evaluations for any person who feels they were injured, either by a heart attack or a bleeding event, while taking the prescription drug Pradaxa®.
Earlier this year, the Archives of Internal Medicine reported on a study which connected the use of Pradaxa®, generically known as Digabatrin, and an increased risk of myocardial infarctions or heart attacks. The study pointed to as much as a 33% increase in the relative risk of suffering a heart attack while taking Pradaxa® for stroke prevention. The study also saw an increased risk for acute coronary syndrome.
In addition to this study, the FDA released a safety communication last December warning patients of possible increased risk for bleeding events while taking Pradaxa®. The FDA warned about a variety of possible bleeding events that could result by taking the drug and warned patients to contact their doctor if they started to suffer any of the following symptoms:
The FDA warning with additional information can be found here. In addition to the FDA, a recent report by the Institute for Safe Medication Practices has reported that Pradaxa® accounted for over 3000 serious adverse events in 2001, including over 500 patient deaths. ISMP, QuaterWatch, May 2012
The attorneys of Kell Lampin, LLC are actively investigating potential Pradaxa® lawsuits nationwide based on these findings. The firm has handled numerous pharmaceutical litigation cases and continues to provide help for families and individuals suffering from injuries caused by defective drugs. A motion to consolidate the currently filed Pradaxa® lawsuits into a federal MDL has already been filed under MDL #2385.
Kell Lampin, LLC is a pharmaceutical litigation law firm located in St. Peters, Missouri just outside of the St. Louis metropolitan area. The firm accepts cases nationwide and helps individuals and families suffering from defective drugs and defective medical devices. Kell Lampin, LLC understands facing a long, complex litigation process can be extremely scary and difficult on individuals and their families. Because of this, the attorneys at Kell Lampin, LLC are dedicated to treating each case with the utmost respect and helping families through the long process.
For more information about Pradaxa® heart attack and bleeding lawsuits call the law firm of Kell Lampin, LLC today. An attorney will provide a free, no obligation, and confidential evaluation of the case to see if a person may be eligible for compensation. Kell Lampin, LLC can be reached at 1-866-804-4357 or through the web at http://www.kelllampinlaw.com
We're here to help.
Call 1-866-640-6397
©Copyright 1997-, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
